ArticleCancers2022

Pre-Training on In Vitro and Fine-Tuning on Patient-Derived Data Improves Deep Neural Networks for Anti-Cancer Drug-Sensitivity Prediction.

Paul Prasse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.